본문 바로가기
intron logo

logo

  • About us
    • BUSINESS
    • R&BD HISTORY
    • OUR EXPERTISE
    • OUR PEOPLE
    • INSIDE iNtRON
  • Platform
    • TECHNOLOGY OVERVIEW
    • PHAGERIARUS®
    • PHAGERUS®
    • PHAGERIA®
    • itLysin®
    • im-MucoDr®
  • AD / BC
    • AD / BC
    • Triangle Hypothesis
  • B.E.C. Project
    • B. E. C. PROJECT
  • Partnering
    • PARTNERING
    • CONTACT
  • Address.

    iNtODEWORLD
    1500 District Avenue,
    Suite 2097, Burlington, MA 01803, USA

    iNtRON Biotechnology
    Suite 701~704, 137, Sagimakgol-ro, Jungwon-gu,
    Seongnam-si, Gyeonggi-do, Republic of Korea

  • Email.

    partner@intron.co.kr

  • [Press Release] iNtRON has confirmed the efficacy of BAL200, a novel e..

    27 January,2023
  • [Press Release] iNtRON is finalizing the SAL200 Tech Transfer

    13 January,2023
  • [Press Release] iNtRON developed advanced bacteriophage engineering pl..

    19 October,2022
  • [Press Release] iNtRON completes the sponsorship transfer process for ..

    25 August,2022
  • [Press Release] iNtRON developed New CRISPR/Cas technology specific fo..

    11 August,2022
  • [Press Release] iNtRON Confirms Efficacy of CDL200 Against CDI Clinica..

    13 July,2022
  • [Press Release] iNtRON to Seek a New Clinical Partner for SAL200 Endol..

    29 June,2022
  • [Press Release] iNtRON Completes GLP-TOX Studies of BAL200

    08 June,2022
  • [Press Release] iNtRON Biotechnology, Inc., Launches New Website

    10 May,2022
  • Immune & Immunotherapeutics

    13 September,2021
1 2 3 4
  • Address.
    iNtODEWORLD
    1500 District Avenue,
    Suite 2097, Burlington, MA 01803, USA
    iNtRON Biotechnology
    Suite 701~704, 137, Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
  • Email.
    partner@intron.co.kr

(C) 2022. iNtODEWORLD. Inc. All rights reserved.